Gastroenterology Center of the Midsouth, PC

Germantown, Tennessee 78212

0 studies enrolling now · 16 studies all time

What they study most

Colitis, Ulcerative, Crohn Disease, Crohn's Disease, Hepatitis C Virus Infection, Hepatitis C, Chronic, Irritable Bowel Syndrome, Ulcerative Colitis

Studies at this site

• ABTECT - Maintenance — Running, not enrolling
• Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease — Completed
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
• A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease — Completed
• A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection — Stopped early
• Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs — Completed
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed
• Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD) — Completed
• Diarrhea Predominant Irritable Bowel Syndrome in Females — Completed
• An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis — Completed
• A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response — Completed
• A Study of Abatacept in Patients With Active Ulcerative Colitis — Completed
• Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease — Completed
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease — Completed
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis — Completed
• A Study of Abatacept in Patients With Active Crohn's Disease — Stopped early